Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1209)	6/24/1998 11:44:00 AM
From: Rudy Saucillo	Read Replies (1) \| Respond to of 2742

<<Why are you sending Messages to yourself?>> Ouch! Actually, I'm not. You're reading them, others on the list are reading them, and CIST is reading them, too! <<I believe that if you ask these business men (via e-mail), with a hint of respect, why they did not do the deals that you recommended, they would give you a reason that you can post here.>> One point in posting relevant news clips is to show that numerous opportunities exist for partnering CIST technology and acquiring or selling assets. Significant opportunities have been missed (e.g., the Genzyme deal), but excellent opportunities remain. I truly believe that Galton/BlueStone are exploring a number of options. But it's time to make decisions and produce something tangible. There's no excuse for CIST to be trading at 1/4 book value. Shareholders need to make their dissatisfaction very clear. Rudy